Myriam Kossai
58 Rue Montalembert
Clermont-ferrand, 63011, France
Clermont-ferrand, 63011, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Development and validation of a PSMA-positive triple-negative breast cancer mouse model for preclinical targeted radionuclide therapies.
Journal: Scientific reports
Published: October 20, 2025
Immunomodulatory intraperitoneal chemotherapy with DACHPt-loaded biomaterial nanoparticles in colorectal carcinomatosis.
Journal: Pharmacological research
Published: September 10, 2025
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.
Journal: Cell reports
Published: April 05, 2025
Comparison of the Predictive and Prognostic Capacities of Neutrophil, Lymphocyte and Platelet Counts and Tumor-infiltrating Lymphocytes in Triple-negative Breast Cancer: Preliminary Results of the PERCEPTION Study.
Journal: Anticancer research
Published: September 03, 2024
Leveraging Deep Learning for Immune Cell Quantification and Prognostic Evaluation in Radiotherapy-Treated Oropharyngeal Squamous Cell Carcinomas.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: July 27, 2024
Case Series of 11 CDH1 Families (47 Carriers) Including Incidental Findings, Signet Ring Cell Colon Cancer and Review of the Literature.
Journal: Genes
Published: July 13, 2023
New-generation technologies for spatial tissue analysis, indispensable tools for deciphering intratumor heterogeneity in the development of antibody-drug conjugates and radio-immunoconjugates for cancer treatment.
Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer
Published: July 05, 2023
Pictorial essay: MRI evaluation of endometriosis-associated neoplasms.
Journal: Insights into imaging
Published: February 09, 2023
Persistent organic pollutants promote aggressiveness in prostate cancer.
Journal: Oncogene
Published: September 15, 2022
Atypical responses to neoadjuvant chemotherapy combined with accelerated partial breast tumor-directed radiotherapy: two cases and considerations for future clinical trials.
Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
Published: August 25, 2022
INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse of Triple Negative Breast Cancer.
Journal: Frontiers in oncology
Published: April 01, 2021
Last Updated: 09/26/2026